Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6250099 | European Urology Focus | 2015 | 10 Pages |
Abstract
Novel urine-, serum-, and tissue-based biomarkers have been validated for guiding decisions on prostate biopsy in asymptomatic men with elevated prostate-specific antigen. Further exploration in this field may help expand their diagnostic and prognostic roles for prostate cancer.
Related Topics
Health Sciences
Medicine and Dentistry
Urology
Authors
Firas Abdollah, Deepansh Dalela, Michael C. Haffner, Zoran Culig, Jack Schalken,